cybercoin market- Top Top stories

Bank of New York Mellon: As the impact weakens, the won may rebound to 1,400 won against the US dollar. Bank of New York Mellon said that as the most serious political impact caused by the short-term declaration of martial law begins to ease, the won may recover some of its recent lost ground before the end of the year. As the political risk premium begins to fall, the won may appreciate to 1,400 against the US dollar.Daiwa Capital Market raised the target price of Tesla from $285 to $420.Mizuho listed in Japan to invest in the ETF of Saudi stock market.

Pakistan KSE-100 index rose 0.5% to 111,504.90.Iflytek and other robot technology companies have a registered capital of 30 million yuan. According to Tianyancha App, Anhui Lingdong General Robot Technology Co., Ltd. was recently established with Hu Guoping as the legal representative and a registered capital of 30 million yuan. Its business scope includes industrial robot manufacturing, industrial robot sales, intelligent robot research and development, electrical equipment sales, computer software and hardware and auxiliary equipment retail, information system integration services, intelligent robot sales, mechanical equipment leasing, etc. According to shareholder information, the company is jointly held by Anhui Xunfei Yunchuang Technology Co., Ltd., a subsidiary of Iflytek (002230), Anhui Yanzhi Technology Co., Ltd. and Anhui Lingji Wanwu Technology Partnership (Limited Partnership).Samsung Electronics will hold its 2025 strategy meeting next week. Yonhap News Agency quoted unnamed industry sources as saying that Samsung Electronics will hold its 2025 global strategy meeting next week. The electronic products business meeting is scheduled to be held on Tuesday and Wednesday, while the semiconductor department meeting will be held on Thursday. The main agenda items include the upcoming Galaxy S25 smartphone. Lee Jae-yong, the company's executive chairman, is not expected to attend these meetings.

An earthquake of magnitude 4.0 occurred in the waters near the Fukushima Daiichi nuclear power plant in Japan. According to Japanese media reports, an earthquake of magnitude 4.0 occurred on the morning of the 12th local time in the eastern coastal area of Fukushima Prefecture, Japan, with a focal depth of 50 kilometers. Fukushima Prefecture has a sense of earthquake in many places, including Urachi-CHO, Langjiang-CHO and Yuye-CHO, among which Urachi is the location of Units 1 to 4 of the Fukushima Daiichi nuclear power plant. (CCTV News)Shanghai Minhang issued 50 opinions to promote high-quality industrial development and strengthen high-quality financial empowerment. The Minhang District People's Government of Shanghai issued the Policy Opinions on High-quality Industrial Development in Minhang District (Trial) on December 12, aiming at improving the basic industrial capacity and the modernization level of industrial chain, accelerating the concentration of various advanced production factors to the development of new-quality productive forces, and promoting the high-quality industrial development in Minhang District. The opinion proposes to strengthen the empowerment of high-quality finance, form a 30 billion yuan "special loan for high-quality development of enterprises in Minhang District", give preferential interest rates to loans, and give subsidies according to a certain proportion of loan interest. Form a credit line of 20 billion yuan "Minhang District Special Loan for Supporting New Infrastructure Construction" to give gradient support to various fixed assets projects.A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)